Skip to main content

Advertisement

SpringerLink
Log in

Polytherapy for the prophylaxis of chronic migraine: an Italian survey

  • Brief Communication
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Chronic migraine (CM) represents an important medical issue, due to morbidity, high disability, presence of comorbidities, and medication overuse (MO). The prophylaxis of CM has not been extensively explored so far. Patients with CM are often treated with two or more compounds, although there is no clear evidence that polytherapy may be superior to monotherapy. We evaluated the percentage of prescription of polytherapy for the prophylaxis of CM in a clinical sample. We examined the charts of 98 CM patients admitted to our Headache Center for inpatient withdrawal program to stop MO. Results showed that only one drug for prophylaxis was prescribed in 20.4% cases, two or more drugs in 79.6%, with 63.3% of the total sample falling in the group “true polytherapy”, i.e. all the drugs prescribed on daily basis were given to treat CM, and not only to treat concomitant conditions. In more than 60% cases a combination of drugs indicated for migraine prophylaxis and drugs only indicated for other conditions (mainly for psychiatric disorders) was prescribed. Our survey indicates that polytherapy may be rather common in CM, and suggests that comorbidities may strongly influence treatment choices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71:559–566

    Article  PubMed  Google Scholar 

  2. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790

    PubMed  CAS  Google Scholar 

  3. Bigal ME, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22(3):269–276

    Article  PubMed  Google Scholar 

  4. Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, Lipton R (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599–609

    PubMed  CAS  Google Scholar 

  5. Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9(4):391–401

    Article  PubMed  Google Scholar 

  6. D’Amico D, Usai S, Grazzi L, Rigamonti A, Solari A, Leone M, Bussone G (2003) Quality of life and disability in primary chronic daily headaches. Neurol Sci 24:S97–S100

    Article  PubMed  Google Scholar 

  7. D’Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G (2005) Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 45:553–560

    Article  PubMed  Google Scholar 

  8. Lanteri-Minet M, Chautard MH, Lucas C (2005) Chronic migraine and medication overuse: results of Framig 3, a French population-based survey carried out according to the 2004 IHS classification. Neurology Suppl 2:A132

    Google Scholar 

  9. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8:1–96

    Google Scholar 

  10. Headache Classification (2004) Subcommittee of the International Headache Society The international classification of headache disorders. Cephalalgia 24:S1–S160

    Google Scholar 

  11. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746

    Article  PubMed  CAS  Google Scholar 

  12. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches. Neurology 47:871–8751

    PubMed  CAS  Google Scholar 

  13. Mathew NT (2009) Dynamic optimization of chronic migraine treatment: current and future options. Neurology 72(Suppl 5):S14–S20

    Article  PubMed  CAS  Google Scholar 

  14. D’Amico D (2010) Pharmacological prophylaxis of chronic migraine. A review of double-blind placebo-controlled trials. Neurol Sci 31(Suppl 1):S23–S28

    Article  PubMed  Google Scholar 

  15. Krymchantowski AV, Silva MT, Barbosa JS, Alves LA (2002) Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 42:510–514

    Article  PubMed  Google Scholar 

  16. Krymchantowski AV, Hampshire F (2004) Polytherapy in migraine prevention. Clinical experience with the combination of a tricyclic antidepressant plus a calcium channel blocker. Headache 44:499–500

    Google Scholar 

  17. Pascual J, Rivas MT, Leira R (2007) Testing the combination betablocker plus topiramate in refractory migraine. Acta Neurol Scand 115:81–83

    Article  PubMed  CAS  Google Scholar 

  18. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS, European Federation of Neurological Societies (2009) EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol 16(9):968–981

    Article  PubMed  CAS  Google Scholar 

  19. Wiendels NJ, van Haestregt A, Knuistingh Neven A, Spinhoven P, Zitman FG, Assendelft WJ, Ferrari MD (2006) Chronic frequent headache in the general population: comorbidity and quality of life. J Neurol Neurosurg Psychiatry 81:428–432

    Google Scholar 

  20. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemogaphic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81:428–432

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that there is no actual or potential conflict of interest in relation to this article.

Author information

Authors and Affiliations

  1. Headache Center, Neurological Institute “C. Besta” IRCCS Foundation, Milan, Italy

    D. D’Amico, M. Curone, V. Tullo, A. Proietti Cecchini, E. Mea & G. Bussone

Authors
  1. D. D’Amico
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Curone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Tullo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Proietti Cecchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Mea
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Bussone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. D’Amico.

Rights and permissions

Reprints and permissions

About this article

Cite this article

D’Amico, D., Curone, M., Tullo, V. et al. Polytherapy for the prophylaxis of chronic migraine: an Italian survey. Neurol Sci 32 (Suppl 1), 185–188 (2011). https://doi.org/10.1007/s10072-011-0521-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-011-0521-8

Keywords

Search

Navigation